anti-CD22 HCAb (Innovative Targeting Solutions)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD22 HCAb (Innovative Targeting Solutions)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCD22 modulators
TargetsCD22
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnovative Targeting Solutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnovative Targeting Solutions Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A